Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders

Status

Completed

Phases

Phase 2Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00036127

Enrollment

Unknown

Registered

2002-05-09

Start date

2002-04-30

Completion date

2003-01-31

Last updated

2013-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Keywords

agitated schizophrenic patients

Brief summary

Study to learn if the alternate formulation is effective in agitated schizophrenic patients

Interventions

DRUGaripiprazole

Study design

Primary purpose

TREATMENT

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Agitated schizophrenic patients

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 8, 2026